LMA ProSeal™ vs. i-Gel™ in ventilated children: A randomised, crossover study using the size 2 mask von GASTEIGER, L, BRIMACOMBE, J, OSWALD, E, PERKHOFER, D, TONIN, A, KELLER, C, TIEFENTHALER, W

Volltext

LMA ProSealTM vs. i-GelTM in ventilated children: A randomised, crossover study using the size 2 mask von GASTEIGER, L., BRIMACOMBE, J., OSWALD, E., PERKHOFER, D., TONIN, A., KELLER, C., TIEFENTHALER, W.

Volltext

Comparison of guided insertion of the LMA ProSeal™ vs the i-gel von GASTEIGER, L, BRIMACOMBE, J, PERKHOFER, D, KAUFMANN, M, KELLER, C

Volltext

ORIGINAL ARTICLE: Comparison of guided insertion of the LMA ProSeal™ vs the i‐gel von Gasteiger, L., Brimacombe, J., Perkhofer, D., Kaufmann, M., Keller, C.

Volltext

LMA P ro S eal TM vs. i‐ G el TM in ventilated children: A randomised, crossover study using the size 2 mask von GASTEIGER, L., BRIMACOMBE, J., OSWALD, E., PERKHOFER, D., TONIN, A., KELLER, C., TIEFENTHALER, W.

Volltext

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group von Seufferlein, T., Uhl, W., Kornmann, M., Algül, H., Friess, H., König, A., Ghadimi, M., Gallmeier, E., Bartsch, D.K., Lutz, M.P., Metzger, R., Wille, K., Gerdes, B., Schimanski, C.C., Graupe, F., Kunzmann, V., Klein, I., Geissler, M., Staib, L., Waldschmidt, D., Bruns, C., Wittel, U., Fichtner-Feigl, S., Daum, S., Hinke, A., Blome, L., Tannapfel, A., Kleger, A., Berger, A.W., Kestler, A.M.R., Schuhbaur, J.S., Perkhofer, L., Tempero, M., Reinacher-Schick, A.C., Ettrich, T.J.

Volltext

299P EvIDHence study: Treatment patterns, duration of treatment and safety outcomes of patients with IDH1-mutated and wild-type cholangiocarcinoma von Melisi, D., Lamarca, A., Blanc, J.F., Perkhofer, L., Gharbi, H., Robert, R., Sahai, V.

Volltext

Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial von Seufferlein, Thomas, Lausser, Ludwig, Stein, Alexander, Arnold, Dirk, Prager, Gerald, Kasper-Virchow, Stefan, Niedermeier, Michael, Müller, Lothar, Kubicka, Stefan, König, Alexander, Büchner-Steudel, Petra, Wille, Kai, Berger, Andreas W, Kestler, Angelika M R, Kraus, Johann M, Werle, Silke D, Perkhofer, Lukas, Ettrich, Thomas J, Kestler, Hans A

Volltext

Using Gaze Behavior to Measure Cognitive Load von Perkhofer, Lisa, Lehner, Othmar

Volltext

TRICC-C: Nintedanib vs. placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: Final results from the randomized phase II trial of the AIO von Ettrich, T J, Berger, A W, Decker, T, Hofheinz, R D, Heinemann, V, Hoffmann, T, Hebart, H F, Herrmann, T, Hannig, C-V, Büchner-Steudel, P, Bartholomäus, H, Güthle, M, Perkhofer, L, Seufferlein, T

Volltext

A novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab: First results of the PERMAD trial von Seufferlein, T, Lausser, L, Stein, A, Prager, G, Kasper, S, Niedermeier, M, Müller, L, Kubicka, S, König, A-O, Büchner-Steudel, P, Wille, K, Perkhofer, L, Hann, A, Berger, A W, Arnold, D, Kestler, H, Ettrich, T J

Volltext

LBA10 Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer: Final results of the NIFE-trial (AIO-YMO HEP-0315), a random... von Perkhofer, L., Striefler, J.K., Sinn, M., Opitz, B., Goetze, T.O., Gallmeier, E., Fischer von Weikersthal, L., Jacobasch, L., Waldschmidt, D., Niedermeier, M., Sohm, M., Sookthai, D., Berger, A., Beutel, A., Seufferlein, T., Ettrich, T.J.

Volltext

A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates von Blum, G., Perkhofer, S., Grif, K., Mayr, A., Kropshofer, G., Nachbaur, D., Kafka-Ritsch, R., Dierich, M.P., Lass-Flörl, C.

Volltext

A biomarker combination indicating resistance to FOLFOX plus bevacizumab in metastatic colorectal cancer: Results of phase I of the PERMAD trial von Seufferlein, T., Ettrich, T.J., Stein, A., Arnold, D., Prager, G., Kasper, S., Niedermeier, M., Mueller, L., Kubicka, S., König, A.-O., Büchner-Steudel, P., Wille, K., Kestler, A., Hann, A., Perkhofer, L., Berger, A.W., Lausser, L., Kestler, H.

Volltext

581PA biomarker combination indicating resistance to FOLFOX plus bevacizumab in metastatic colorectal cancer: Results of phase I of the PERMAD trial von Seufferlein, T, Ettrich, T J, Stein, A, Arnold, D, Prager, G, Kasper, S, Niedermeier, M, Mueller, L, Kubicka, S, König, A-O, Büchner-Steudel, P, Wille, K, Kestler, A, Hann, A, Perkhofer, L, Berger, A W, Lausser, L, Kestler, H

Volltext

581P - A biomarker combination indicating resistance to FOLFOX plus bevacizumab in metastatic colorectal cancer: Results of phase I of the PERMAD trial von Seufferlein, T., Ettrich, T.J., Stein, A., Arnold, D., Prager, G., Kasper, S., Niedermeier, M., Mueller, L., Kubicka, S., König, A.-O., Büchner-Steudel, P., Wille, K., Kestler, A., Hann, A., Perkhofer, L., Berger, A.W., Lausser, L., Kestler, H.

Volltext

474PA novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab: First results of the PERMAD trial von Seufferlein, T, Lausser, L, Stein, A, Prager, G, Kasper, S, Niedermeier, M, Müller, L, Kubicka, S, König, A-O, Büchner-Steudel, P, Wille, K, Perkhofer, L, Hann, A, Berger, A W, Arnold, D, Kestler, H, Ettrich, T J

Volltext

564PTRICC-C: Nintedanib vs. placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: Final results from the randomized phase II trial of the AIO von Ettrich, T J, Berger, A W, Decker, T, Hofheinz, R D, Heinemann, V, Hoffmann, T, Hebart, H F, Herrmann, T, Hannig, C-V, Büchner-Steudel, P, Bartholomäus, H, Güthle, M, Perkhofer, L, Seufferlein, T

Volltext

Immune evasion by acquisition of complement inhibitors: The mould Aspergillus binds both factor H and C4b binding protein von Vogl, G., Lesiak, I., Jensen, D.B., Perkhofer, S., Eck, R., Speth, C., Lass-Flörl, C., Zipfel, P.F., Blom, A.M., Dierich, M.P., Würzner, R.

Volltext

Détection de l’ADN circulant de pneumocystis dans les différents compartiments sanguins au cours de la pneumocystose von Frealle, E., Gantois, N., Leroy, S., Zawadzki, C., Aliouat-Denis, C.M., Perkhofer, S., Dei-Cas, E., El Aliouat, M.

Volltext